Professional Documents
Culture Documents
ABSTRACT
Cancerant
igen(CA)125 isagl
ycoproteinproducedbyepit
heli
alovari
um t
umorsandmesothel
ialcel
ls,itslevelsal
so
havebeen shown to beelevated in patientswi
th Non-Hodgkin’
sLymphoma(NHL). Severalpapershavereport
ed an
associ
ati
onofhighCA 125 serum levelswithadvancedNHLaswellasrelati
onshi
pbet
weenhi ghCA 125 valuesandpoor
out
come. Thi
sstudyaimedtodetermineassociat
ionbetweenCA 125 l
evels(>35 U/ml)wit
hnormalCA 125 ( 35 U/ml)
tot
heresponeofNHL patientsreceivingchemotherapyCHOP. Anobservati
onalanal
yti
cprospecti
vest
udywasdonei n
40 pat
ient
swi thNHL atDrSoetomoHospitalSurabaya. Thepat ientwererecrui
tedfrom bot
hinpat
ientandoutpat
ient
cl
inicandt heinitialCA 125 levelhaddetermi
nedbeforet
hepat
ientsrecei
vedchemotherapywithCyclophosphamide,
Doxorubi
cin,VincristineandPrednisone(CHOP).Ofthe40 pat
ientswhoincludedinthisstudy,62.5% weremale,37.5%
werefemale,t
heaverageage43, 45 years,themostki
ndofhistophat
ologyresultwerediffuselargecell,cl
eavedornon
cleavedcel
l(47.5%). TherewasasigniÞcantassociationbet
weenCA 125 l
evelswiththerapyresponegroups(responi
ve
andunresponive),withsigni
Þcancy0.001 (OR 23.22;CI95%),andwiththerapyresponegroups(CR,PR,NC,PD)wi t
h
signi
Þcancy0.013. ThegroupwithnormalCA 125 l
evel
s( 35 U/
ml),hadbet
terrespone,i
twasaround95% responive
(CR = 35%,PR = 60%)and5% unresponive(NC = 5%,PD = 0%)t hanthegroupwhohadhi ghCA 125 levels(> 35
U/ml),i
twasonly45% responive(CR = 15%,PR = 30% and55% unresponive(NC = 50%,PD = 5%).Asaconclusion,
l
evel
sofCA 125 (> 35 U/ml)perhapscouldbeanegati
veprognost
icfactortopredi
cttheCHOPchemot herapyrespone
i
nNHL pat
ients.
Keywords:AggressiveNon-Hodgkin’
sLymphoma,CA 125
Gambar8. Asosi
asiCA 125 denganresponsterapi(CR,
PR,NC,PD)
PEM BAHASAN